A number of drugs are now available treat the cognitive and behavioral symptoms
of Alzheimer's. In addition, a variety of medications have been associated with
significant reductions in the risk of developing Alzheimer's, and may be prescribed
in hope of slowing the progression of disease in individuals who have already developed
symptoms. However, these medications have yet to be proven to be effective in slowing
the disease course. Unfortunately, there is no cure yet, but promising new compounds
are being tested constantly.
An important recent development is that research now shows that individuals with
mild cognitive impairment are at a very high risk of developing Alzheimer's disease.
A number of ongoing clinical trials are recruiting such individuals to test whether
certain drugs are effective in reducing the rate at which they progress to Alzheimer's
disease. It is expected that future clinical trials will focus increasingly on early